Konstantinos Arnaoutakis, MD
Full Member
|
| Research Program:
Cancer Therapeutics
Faculty Rank:
Associate Professor
Campus:
University of Arkansas for Medical Sciences
College:
College of Medicine
Department:
Internal Med Hem-Onc
|
Cancer Research Interest
- Disease Site Focus: Thoracic/ Lung
- Research Focus Area: Treatment, Diagnosis/ Prognosis
- Type of Research: Clinical
Contact Information
- Email Address: KARNAOUTAKIS@UAMS.EDU
- Profiles Research Networking Software: View Profile
Open Clinical Trials
- “S1900K A Randomized Phase II Study of Tepotinib with or Without Ramucirumab in Participants with MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)” (NCT06031688)
- “S1900G, “A Randomized Phase II Study of INC280 (capmatinib) plusOsimertinib with or without Ramucirumab in Participants with EGFR-Mutant, METAmplifiedStage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)”” (NCT05096663)
- “S1900E, A Phase II Study of AMG 510 in Participants with Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN LUNG-MAP SUB-STUDY)” (NCT04625647)
- “LUNGMAP - A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)” (NCT03851445)
Recent Publications
- Dizman N, Bakouny Z, Haykal T, [et al., including Arnaoutakis K]. Guide to Understanding and Supporting International Medical Graduates in Hematology/Oncology by the ASCO International Medical Graduates Community of Practice. JCO oncology practice. 2024:OP2400565. PMID: 39374449.
- Arnaoutakis K, Wan Y, Elliott J, [et al.]. Real-World Treatment Patterns and Outcomes Across Three Lines of Therapy in Patients with ALK+ NSCLC. Advances in therapy. 2024. PMID: 38916812. PMCID: PMC11263478.
- Tu SM, Trikannad AK, Vellanki S, [et al., including Arnaoutakis K]. Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care. Cancers. 2024 16(6). PMID: 38539487. PMCID: PMC10969562.
- Tu SM, Singh SR, Arnaoutakis K, [et al.]. Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench. Cancers. 2022 14(14). PMID: 35884406. PMCID: PMC9321703.
- Makhoul I, Anders M, Siegel R, [et al., including Arnaoutakis K]. Hematology/Oncology Fellowship Programs' Participation in the Quality Oncology Practice Initiative. JCO oncology practice. 2022:OP2100807. PMID: 35467961.
- Ma L, Peterson EA, Shin IJ, [et al., including Arnaoutakis K]. An advanced molecular medicine case report of a rare human tumor using genomics, pathomics, and radiomics. Frontiers in genetics. 2022 13:987175. PMID: 36846293. PMCID: PMC9951004.